Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 16, 2023
Acthar Gel Inhibits the Activation of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells
Dale Wright, Kyle Hayes
Neuroimmunomodulation
|
August 10, 2025
Melanocortin Receptor-Mediated Anti-Inflammatory Effect of Acthar® Gel in Human Myeloid Cells
Kyle Hayes, Dale Wright
Physiological Reports
|
April 14, 2025
Microarray analysis of the effects of Acthar Gel versus methylprednisolone in a model of focal segmental glomerulosclerosis in female rats
Kyle Hayes, Dale Wright
Journal of Comparative Effectiveness Research
|
November 11, 2024
A novel injection device to administer repository corticotropin injection for inflammatory disease treatment: findings from a market research study
Sheila Elliott, Priya Miranda, Kyle Hayes
Clinicoeconomics and Outcomes Research : CEOR
|
July 3, 2023
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
George J Wan, John Niewoehner, Kyle Hayes
Rheumatology and Therapy
|
January 5, 2021
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
Kyle Hayes, Mary P Panaccio, Niti Goel, et al.
Plos One
|
September 20, 2024
Forward variable selection enables fast and accurate dynamic system identification with Karhunen-Loève decomposed Gaussian processes
Kyle Hayes, Michael W Fouts, Ali Baheri, et al.
BMC Nephrology
|
June 17, 2020
Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Kyle Hayes, Elizabeth Warner, Chris Bollinger, et al.
BMC Nephrology
|
July 18, 2020
Correction to: Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Kyle Hayes, Elizabeth Warner, Chris Bollinger, et al.
Advances in Therapy
|
May 31, 2022
Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review
Cynthia Girman, Mary P Panaccio, Kyle Hayes, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 16, 2023
Acthar Gel Inhibits the Activation of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells
Dale Wright, Kyle Hayes
Neuroimmunomodulation
|
August 10, 2025
Melanocortin Receptor-Mediated Anti-Inflammatory Effect of Acthar® Gel in Human Myeloid Cells
Kyle Hayes, Dale Wright
Physiological Reports
|
April 14, 2025
Microarray analysis of the effects of Acthar Gel versus methylprednisolone in a model of focal segmental glomerulosclerosis in female rats
Kyle Hayes, Dale Wright
Journal of Comparative Effectiveness Research
|
November 11, 2024
A novel injection device to administer repository corticotropin injection for inflammatory disease treatment: findings from a market research study
Sheila Elliott, Priya Miranda, Kyle Hayes
Clinicoeconomics and Outcomes Research : CEOR
|
July 3, 2023
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
George J Wan, John Niewoehner, Kyle Hayes
Rheumatology and Therapy
|
January 5, 2021
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
Kyle Hayes, Mary P Panaccio, Niti Goel, et al.
Plos One
|
September 20, 2024
Forward variable selection enables fast and accurate dynamic system identification with Karhunen-Loève decomposed Gaussian processes
Kyle Hayes, Michael W Fouts, Ali Baheri, et al.
BMC Nephrology
|
June 17, 2020
Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Kyle Hayes, Elizabeth Warner, Chris Bollinger, et al.
BMC Nephrology
|
July 18, 2020
Correction to: Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Kyle Hayes, Elizabeth Warner, Chris Bollinger, et al.
Advances in Therapy
|
May 31, 2022
Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review
Cynthia Girman, Mary P Panaccio, Kyle Hayes, et al.
Page
of 4